Correlation Between Gracell Biotechnologies and Xilio Development

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Gracell Biotechnologies and Xilio Development at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gracell Biotechnologies and Xilio Development into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gracell Biotechnologies and Xilio Development, you can compare the effects of market volatilities on Gracell Biotechnologies and Xilio Development and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gracell Biotechnologies with a short position of Xilio Development. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gracell Biotechnologies and Xilio Development.

Diversification Opportunities for Gracell Biotechnologies and Xilio Development

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Gracell and Xilio is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Gracell Biotechnologies and Xilio Development in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xilio Development and Gracell Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gracell Biotechnologies are associated (or correlated) with Xilio Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xilio Development has no effect on the direction of Gracell Biotechnologies i.e., Gracell Biotechnologies and Xilio Development go up and down completely randomly.

Pair Corralation between Gracell Biotechnologies and Xilio Development

If you would invest  97.00  in Xilio Development on December 28, 2024 and sell it today you would lose (24.00) from holding Xilio Development or give up 24.74% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Gracell Biotechnologies  vs.  Xilio Development

 Performance 
       Timeline  
Gracell Biotechnologies 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Gracell Biotechnologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent fundamental indicators, Gracell Biotechnologies is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.
Xilio Development 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Xilio Development are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very weak essential indicators, Xilio Development displayed solid returns over the last few months and may actually be approaching a breakup point.

Gracell Biotechnologies and Xilio Development Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Gracell Biotechnologies and Xilio Development

The main advantage of trading using opposite Gracell Biotechnologies and Xilio Development positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gracell Biotechnologies position performs unexpectedly, Xilio Development can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xilio Development will offset losses from the drop in Xilio Development's long position.
The idea behind Gracell Biotechnologies and Xilio Development pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
CEOs Directory
Screen CEOs from public companies around the world
Stocks Directory
Find actively traded stocks across global markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume